hit counter
Natus Medical Incorporated (BABY) Stock News Sentiment & Price - Sentifly
BABY - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Natus Medical Incorporated (BABY)

BABY Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BABY Latest news
The Motley Fool
Neutral
Is Natus Medical Stock a Buy?
2020-05-31 06:53

What should investors think of this infant care and neurology specialist?

Seeking Alpha
Neutral
Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q1 2020 Results - Earnings Call Transcript
2020-05-02 09:43

Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research
Negative
Natus Medical (NTUS) Lags Q1 Earnings and Revenue Estimates
2020-04-30 18:55

Natus Medical (NTUS) delivered earnings and revenue surprises of -81.82% and -0.11%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research
Positive
Natus Medical (NTUS) Earnings Expected to Grow: Should You Buy?
2020-04-23 12:32

Natus Medical (NTUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire
Neutral
Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors
2020-03-20 08:00

PLEASANTON, Calif., March 20, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced the appointment of Ilan Daskal, current Chief Financial Officer & Executive Vice President of Bio-RAD Laboratories, to its board of directors and audit committee effective March 19, 2020. The Company will also nominate Mr. Daskal at its 2020 Annual Meeting of Stockholders.

The Motley Fool
Negative
Here's Why NuVasive, Exelixis, and Natus Medical Fell Today
2020-03-12 17:40

The healthcare companies couldn't sidestep the COVID-19 slump.

Seeking Alpha
Neutral
Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q3 2019 Results - Earnings Call Transcript
2019-10-26 09:29

Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q3 2019 Results - Earnings Call Transcript

Zacks Investment Research
Negative
Natus Medical (NTUS) Misses Q3 Earnings and Revenue Estimates
2019-10-24 19:05

Natus Medical (NTUS) delivered earnings and revenue surprises of -5.26% and -1.03%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire
Neutral
Natus Medical Announces Third Quarter 2019 Financial Results
2019-10-24 16:05

PLEASANTON, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced financial results for the three and nine months ended September 30, 2019.

Zacks Investment Research
Positive
Natus Medical (BABY) Q2 Earnings and Revenues Top Estimates
2019-07-25 20:05

Natus Medical (BABY) delivered earnings and revenue surprises of 13.33% and 2.19%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Loading more news...